Akums Drugs and Pharmaceutical (AKUMS) — Financial Flexibility Index
Akums Drugs and Pharmaceutical (AKUMS) has a Financial Flexibility Index of 0.70x as of March 2025. Free cash flow of Rs7.38 Billion (operating CF Rs4.65 Billion minus capex Rs2.72 Billion) represents 1% of total liabilities (Rs10.50 Billion). Also explore Akums Drugs and Pharmaceutical annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Akums Drugs and Pharmaceutical Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for Akums Drugs and Pharmaceutical across 4 annual periods. Check how resilient are Akums Drugs and Pharmaceutical's assets to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for Akums Drugs and Pharmaceutical (2022–2025)
Year-by-year free cash flow to debt coverage for Akums Drugs and Pharmaceutical. For the full company profile including market capitalisation, see market value of Akums Drugs and Pharmaceutical.
| Year | Flexibility Index | Free Cash Flow (INR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.70x | Rs7.38 Billion | Rs4.65 Billion | Rs10.50 Billion | ▲ +142.6% |
| 2024 | 0.29x | Rs8.10 Billion | Rs4.98 Billion | Rs27.96 Billion | ▲ +45.7% |
| 2023 | 0.20x | Rs5.05 Billion | Rs1.77 Billion | Rs25.43 Billion | ▲ +67.8% |
| 2022 | 0.12x | Rs2.89 Billion | Rs318.54 Million | Rs24.44 Billion | — |